The cerebellum is commonly affected in PMM2-CDG, dystroglycanopathies, and SRD5A3-CDG, while the course of cerebellar ataxia is not progressive (25–28). The gene discussed is SRD5A3; the disease is neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan.